We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · May 17, 2022

Single Low-Dose Targeted Bevacizumab Infusion in Adult Patients With Steroid-Refractory Brain Radiation Necrosis

Journal of Neurosurgery

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Neurosurgery
Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial
J. Neurosurg. 2022 Apr 15;[EPub Ahead of Print], SR Dashti, RJ Kadner, BS Folley, JP Sheehan, DY Han, RJ Kryscio, MB Carter, LBE Shields, BM Plato, RV La Rocca, AC Spalding, TL Yao, JF Fraser

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading